Biotech-igG AB logo

BIGG B - Biotech-igG AB Share Price

SEK0.045 0.0  0.0%

Last Trade - 06/10/17

Sector
Healthcare
Size
Micro Cap
Market Cap £n/a
Enterprise Value £n/a
Revenue £3.63m
Position in Universe th / 1850
Bullish
Bearish
Unlock BIGG B Revenue
Momentum
Relative Strength (%)
1m -49.2%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2014 2015 2016 2017 2018 2019 2020E 2021E CAGR / Avg
6.35 6.20 5.39 4.39 25.0 39.3 +44.0%
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the six months ended 30 June 2020, Biotech-igGAB revenues increased 32% to SEK14.2M. Net loss increasedfrom SEK437K to SEK1.5M. Revenues reflect EquityAdministration increase of 74% to SEK11.9M. Higher net lossreflects Financial Items decrease from SEK328K (income) toSEK71K (expense), Depreciation/Amortization increase of 13%to SEK17K (expense).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

BIGG B Revenue Unlock BIGG B Revenue

Net Income

BIGG B Net Income Unlock BIGG B Revenue

Normalised EPS

BIGG B Normalised EPS Unlock BIGG B Revenue

PE Ratio Range

BIGG B PE Ratio Range Unlock BIGG B Revenue

Dividend Yield Range

BIGG B Dividend Yield Range Unlock BIGG B Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
BIGG B EPS Forecasts Unlock BIGG B Revenue
Profile Summary

Biotech-IgG AB, formerly Chemel AB (publ), is a Sweden-based supplier of products for research, routine and process scale applications for the biotechnology, molecular biology and immunodiagnostics markets. Its product portfolio comprises SIRE, a biosensor device for analyzing small molecules, such as glucose, for antibody production, and BITAR equipment for the analyzing of antibodies. Additionally, the Company offers services within the purification of proteins. As of December 31, 2011, the Company owned two subsidiaries, Biotech-IgG A/S, engaged in the marketing activities in the Nordic countries and the European Union, and Biotech-IgG Ltd, which discontinued its operations. As of December 31, 2011, the Company’s two largest shareholders were the European Institute of Science (4.8%) and Ajust Holding A/S (4.7%).

Directors
Last Annual December 31st, 2019
Last Interim June 30th, 2020
Public Since May 3, 2010
No. of Shareholders: n/a
No. of Employees: 3
Sector Healthcare
Industry Healthcare Equipment & Supplies
Index
Exchange AktieTorget Stock Exchange
Shares in Issue 839,064,527
Free Float (0.0%)
Eligible for
ISAs
SIPPs
BIGG B Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for BIGG B
Upcoming Events for BIGG B
Frequently Asked Questions for Biotech-igG AB
What is the Biotech-igG AB share price?

As of 06/10/17, shares in Biotech-igG AB are trading at SEK0.045, giving the company a market capitalisation of £n/a. This share price information is delayed by 15 minutes.

How has the Biotech-igG AB share price performed this year?

Shares in Biotech-igG AB are currently trading at SEK0.045 and the price has moved by -73.3% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Biotech-igG AB price has moved by -75.89% over the past year.

What are the analyst and broker recommendations for Biotech-igG AB?

There are no analysts currently covering Biotech-igG AB.

When will Biotech-igG AB next release its financial results?

Biotech-igG AB is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-06-30
What is the Biotech-igG AB dividend yield?

Biotech-igG AB does not currently pay a dividend.

Does Biotech-igG AB pay a dividend?

Biotech-igG AB does not currently pay a dividend.

When does Biotech-igG AB next pay dividends?

Biotech-igG AB does not currently pay a dividend.

How do I buy Biotech-igG AB shares?

To buy shares in Biotech-igG AB you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Biotech-igG AB?

Shares in Biotech-igG AB are currently trading at SEK0.045, giving the company a market capitalisation of £n/a.

Where are Biotech-igG AB shares listed? Where are Biotech-igG AB shares listed?

Here are the trading details for Biotech-igG AB:

Country of listing: Sweden
Exchange: AKT
Ticker Symbol: BIGG B
What kind of share is Biotech-igG AB?

We were not able to load our ranking data for Biotech-igG AB

Is there a Biotech-igG AB share price forecast 2021?

We were not able to load any forecast data for Biotech-igG AB.

How can I tell whether the Biotech-igG AB share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Biotech-igG AB. Over the past six months, the relative strength of its shares against the market has been -52.53%. At the current price of SEK0.045, shares in Biotech-igG AB are trading at % against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Biotech-igG AB PE Ratio?

We were not able to find PE ratio data for Biotech-igG AB.

Who are the key directors of Biotech-igG AB?

Biotech-igG AB's management team is headed by:

Edvard Skodic - IND
Helene Vester - CFO
Ulric Aspegren - IND
Kirstin Kriz - CEX
Lars-Olof Hansson - DRC
Mats Andersson - CHM
Anders Edvardsson - CEO
Who are the major shareholders of Biotech-igG AB?

Here are the top five shareholders of Biotech-igG AB based on the size of their shareholding:

Similar to BIGG B
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.